This company listing is no longer active
Initiator Pharma Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Belangrijke informatie
-21.6%
Groei van de winst
23.8%
Groei van de winst per aandeel
| Biotechs Groei van de industrie | 0.7% |
| Inkomstengroei | n/a |
| Rendement op eigen vermogen | -177.3% |
| Nettomarge | n/a |
| Volgende winstupdate | 26 Aug 2022 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe Initiator Pharma geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 22 | 0 | -34 | 2 | 0 |
| 31 Dec 21 | 0 | -21 | 1 | 0 |
| 30 Sep 21 | 0 | -16 | 1 | 0 |
| 30 Jun 21 | 0 | -10 | 1 | 0 |
| 31 Mar 21 | 0 | -8 | 1 | 0 |
| 31 Dec 20 | 0 | -9 | 1 | 0 |
| 30 Sep 20 | 0 | -10 | 1 | 0 |
| 30 Jun 20 | 0 | -9 | 1 | 0 |
| 31 Mar 20 | 0 | -9 | 1 | 0 |
| 31 Dec 19 | 0 | -8 | 1 | 0 |
| 30 Sep 19 | 0 | -7 | 1 | 0 |
| 30 Jun 19 | 0 | -9 | 1 | 0 |
| 31 Mar 19 | 0 | -8 | 1 | 0 |
| 31 Dec 18 | 0 | -10 | 1 | 0 |
| 30 Sep 18 | 0 | -13 | 1 | 0 |
| 30 Jun 18 | 0 | -11 | 1 | 0 |
| 31 Mar 18 | 0 | -10 | 1 | 0 |
| 31 Dec 17 | 0 | -9 | 1 | 0 |
| 30 Sep 17 | 0 | -7 | 1 | 0 |
Kwaliteitswinsten: INIT BTA is currently unprofitable.
Groeiende winstmarge: INIT BTA is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: INIT BTA is unprofitable, and losses have increased over the past 5 years at a rate of 21.6% per year.
Versnelling van de groei: Unable to compare INIT BTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: INIT BTA is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-12.6%).
Rendement op eigen vermogen
Hoge ROE: INIT BTA has a negative Return on Equity (-177.26%), as it is currently unprofitable.